packagePolyICLC

poly ICLC

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Poly ICLC (Hiltonol) is an immunostimulant investigated as a treatment for cancer. It remains investigational and is not an approved medicine in the European Union or elsewhere.

Summary written by glm-5.3-flash from Wikidata Q7226111 and the WHO ATC classification; not checked by a person.

name:poly ICLC
ATC codes:L03AX08
DrugBank:DB17293
Wikidata:Q7226111

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown